Objective: To evaluate sex, age at diabetes onset, puberty, and HbA, with subjects followed from diabetes diagnosis and during different time periods, as risk factors for developing diabetic simplex and proliferative retinopathy.

Research Design And Methods: In a population-based observational study, HbA for 451 patients diagnosed with diabetes before 35 years of age during 1983-1987 in southeast Sweden was followed for up to 18-24 years from diagnosis. Long-term mean weighted HbA (wHbA) was calculated. Retinopathy was evaluated by fundus photography and analyzed in relation to wHbA levels.

Results: Lower wHbA, diabetes onset ≤5 years of age, and diabetes onset before puberty, but not sex, were associated with longer time to appearance of simplex retinopathy. Proliferative retinopathy was associated only with wHbA. The time to first appearance of any retinopathy decreased with increasing wHbA. Lower wHbA after ≤5 years' diabetes duration was associated with later onset of simplex retinopathy but not proliferative retinopathy. With time, most patients developed simplex retinopathy, except for those of the category wHbA ≤50 mmol/mol (6.7%), for which 20 of 36 patients were without any retinopathy at the end of the follow-up in contrast to none of 49 with wHbA >80 mmol/mol (9.5%).

Conclusions: Onset at ≤5 years of age and lower wHbA the first 5 years after diagnosis are associated with longer duration before development of simplex retinopathy. There is a strong positive association between long-term mean HbA measured from diagnosis and up to 20 years and appearance of both simplex and proliferative retinopathy.

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-1950DOI Listing

Publication Analysis

Top Keywords

simplex retinopathy
16
onset puberty
12
diabetes onset
12
years age
12
lower whba
12
proliferative retinopathy
12
retinopathy
11
whba
9
age diabetes
8
simplex proliferative
8

Similar Publications

Neurodegenerative pathologies such as age-related macular degeneration currently have no cure or effective treatment. In this type of disease, the presence of amyloid-β peptides, oxidative stress, and inflammation trigger dysregulation of retinal pigment epithelial cells and progression toward the death of these cells, resulting in a loss of vision. The production of amyloid-β peptides, oxidative stress, and inflammation can be triggered in response to viral infections.

View Article and Find Full Text PDF

[Viral retinitis].

J Fr Ophtalmol

December 2024

Service d'ophtalmologie, Sorbonne université, CHU Pitié-Salpêtrière, Paris, France.

Viruses belonging to the herpes family group, including HSV (herpes simplex virus) 1 and 2, VZV (varicella zoster virus) and CMV (cytomegalovirus) are the leading causes of necrotizing retinitis. These viral retinal necroses generally manifest in three forms, depending on the patient's immune status: acute retinal necrosis (ARN), progressive outer retinal necrosis (PORN) and CMV retinitis. Although specific, effective drug treatments are available today, early treatment initiation is essential to avoid sight-threatening complications.

View Article and Find Full Text PDF

Reactivation of herpes simplex virus 2 presenting as recurrent acute retinal necrosis following COVID-19 vaccination.

Int J Infect Dis

October 2024

Department of Ophthalmology and Visual Science, Kochi Medical School, Kochi University, Nankoku City, Kochi, Japan.

Article Synopsis
  • Acute retinal necrosis (ARN) is a serious eye condition linked to the reactivation of herpesviruses, potentially triggered by COVID-19 infection or vaccination.
  • A 58-year-old Japanese woman developed ARN in her left eye due to herpes simplex virus 2 shortly after receiving her fifth dose of the COVID-19 vaccine, despite having a history of ARN in her right eye.
  • The case highlights the possibility that individuals with previous ARN may face a higher risk of recurrence following COVID-19 vaccination due to viral reactivation.
View Article and Find Full Text PDF
Article Synopsis
  • - A case of cytomegalovirus (CMV) neuroretinitis was reported in an immunocompetent patient who had blurred vision in both eyes, with an unusual fundus appearance in the left eye, complicating the diagnosis due to the absence of typical risk factors.
  • - The diagnosis was confirmed and the patient received oral treatment with valganciclovir, resulting in a positive response and highlighting the medication's effectiveness for CMV-related ocular conditions.
  • - This case emphasizes the need for ophthalmologists to consider rare infections like CMV in patients without common immunocompromising conditions, advocating for early diagnosis and treatment to prevent vision loss.
View Article and Find Full Text PDF

Acquired Cytomegalovirus Retinitis in Preterm Infant Hospitalized in the NICU: A Noteworthy Case Report.

Adv Neonatal Care

August 2024

School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran (Dr Tajalli and Mr Vafaee); and Neonatal Health Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran (Drs Safi, Navidi Moghaddam, and Fallahi).

Background: Acquired human cytomegalovirus (CMV) is a noteworthy disease in infants. This case study will highlight the influence of early diagnosis of CMV retinitis (CMVR) on avoid visual impairment.

Clinical Findings: We describe a preterm female infant with a birth weight of 2060 gr that was admitted for tracheostomy placement due to hypoxic-ischemic encephalopathy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!